Avadel Pharmaceuticals Files 8-K
| Field | Detail |
|---|---|
| Company | Avadel Pharmaceuticals PLC |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: AVDL
TL;DR
Avadel filed an 8-K on 6/27/25, check for updates.
AI Summary
On June 27, 2025, Avadel Pharmaceuticals plc filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or material events were detailed in the provided excerpt, suggesting a routine or administrative filing.
Why It Matters
This filing signals an update or event from Avadel Pharmaceuticals, requiring investors to check the full report for any material disclosures that could impact the company's stock.
Risk Assessment
Risk Level: low — The provided excerpt of the 8-K filing does not contain specific details about material events or financial transactions, indicating a low immediate risk based on this information alone.
Key Players & Entities
- AVADEL PHARMACEUTICALS PLC (company) — Registrant
- June 27, 2025 (date) — Date of Report
- Ireland (location) — State of incorporation
- 001-37977 (identifier) — Commission File Number
- 98-1341933 (identifier) — IRS Employer Identification No.
- 10 Earlsfort Terrace Dublin 2, Ireland, D02 T380 (address) — Principal executive offices
- + 353 1 901 5201 (phone_number) — Registrant's telephone number
FAQ
What specific event triggered this 8-K filing for Avadel Pharmaceuticals?
The filing indicates 'Other Events' as the item information, but the provided excerpt does not detail the specific event.
When was this 8-K report filed?
The report was filed on June 27, 2025.
What is Avadel Pharmaceuticals' principal executive office address?
The principal executive offices are located at 10 Earlsfort Terrace Dublin 2, Ireland, D02 T380.
What is the Commission File Number for Avadel Pharmaceuticals?
The Commission File Number is 001-37977.
What is the registrant's telephone number?
The registrant's telephone number is + 353 1 901 5201.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding AVADEL PHARMACEUTICALS PLC.